Literature DB >> 10737882

In vivo biocompatibility of dextran-based hydrogels.

J A Cadée1, M J van Luyn, L A Brouwer, J A Plantinga, P B van Wachem, C J de Groot, W den Otter, W E Hennink.   

Abstract

Dextran-based hydrogels were obtained by polymerization of aqueous solutions of methacrylated dextran (dex-MA) or lactate-hydroxyethyl methacrylate-derivatized dextran (dex-lactate-HEMA). Both nondegradable dex-MA and degradable dex-lactate-HEMA disk-shaped hydrogels, varying in initial water content and degree of substitution (DS, the number of methacrylate groups per 100 glucose units), were implanted subcutaneously in rats. The tissue reaction was evaluated over a period of 6 weeks. The initial foreign-body reaction to the dex-MA hydrogels was characterized by infiltration of granulocytes and macrophages and the formation of fibrin, and exudate, as well as new blood vessels. This reaction depended on the initial water content as well as on the DS of the hydrogel and decreased within 10 days. The mildest tissue response was observed for the gel with the highest water content and intermediate DS. At day 21 all dex-MA hydrogels were surrounded by a fibrous capsule and no toxic effects on the surrounding tissue were found. No signs of degradation were observed. The initial foreign-body reaction to the degradable dex-lactate-HEMA hydrogels was less severe compared with the dex-MA gels. In general, the size of the dex-lactate-HEMA hydrogels increased progressively with time and finally the gels completely dissolved. Degradation of the dex-lactate-HEMA hydrogels was associated with infiltration of macrophages and the formation of giant cells, both of which phagocytosed pieces of the hydrogel. A good correlation between the in vitro and the in vivo degradation time was found. This suggests that extra-cellular degradation is not caused by enzymes but depends only on hydrolysis of the ester and/or carbonate bonds present in the crosslinks of the hydrogels. After 21 days, the degradable hydrogels, as such, could not be retrieved, but accumulation of macrophages and giant cells was observed, both of which contained particles of the gels intracellularly. As for the dex-MA hydrogels, no toxic effects on the surrounding tissue were found. The results presented in this study demonstrate that dextran-based hydrogels can be considered as biocompatible materials, making these hydrogels attractive systems for drug delivery purposes. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737882     DOI: 10.1002/(sici)1097-4636(20000605)50:3<397::aid-jbm14>3.0.co;2-a

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  10 in total

1.  Glucose sensor membranes for mitigating the foreign body response.

Authors:  Ahyeon Koh; Scott P Nichols; Mark H Schoenfisch
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

Review 2.  Current progress in Reactive Oxygen Species (ROS)-Responsive materials for biomedical applications.

Authors:  Sue Hyun Lee; Mukesh K Gupta; Jae Beum Bang; Hojae Bae; Hak-Joon Sung
Journal:  Adv Healthc Mater       Date:  2013-01-25       Impact factor: 9.933

3.  Functionalized, biodegradable hydrogels for control over sustained and localized siRNA delivery to incorporated and surrounding cells.

Authors:  Khanh Nguyen; Phuong Ngoc Dang; Eben Alsberg
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

Review 4.  Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances.

Authors:  Fei Wu; Tuo Jin
Journal:  AAPS PharmSciTech       Date:  2008-12-16       Impact factor: 3.246

5.  Injectable and in situ gelling hydrogels for modified protein release.

Authors:  L Pescosolido; S Miatto; C Di Meo; C Cencetti; T Coviello; F Alhaique; Pietro Matricardi
Journal:  Eur Biophys J       Date:  2009-03-27       Impact factor: 1.733

6.  Dextran-Mimetic Quantum Dots for Multimodal Macrophage Imaging In Vivo, Ex Vivo, and In Situ.

Authors:  Hongping Deng; Christian J Konopka; Suma Prabhu; Suresh Sarkar; Natalia Gonzalez Medina; Muhammad Fayyaz; Opeyemi H Arogundade; Hashni Epa Vidana Gamage; Sayyed Hamed Shahoei; Duncan Nall; Yeoan Youn; Iwona T Dobrucka; Christopher O Audu; Amrita Joshi; William J Melvin; Katherine A Gallagher; Paul R Selvin; Erik R Nelson; Lawrence W Dobrucki; Kelly S Swanson; Andrew M Smith
Journal:  ACS Nano       Date:  2022-02-02       Impact factor: 15.881

7.  A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles.

Authors:  Yuangang Zu; Dan Wang; Xiuhua Zhao; Ru Jiang; Qi Zhang; Dongmei Zhao; Yong Li; Baishi Zu; Zhiqiang Sun
Journal:  Int J Mol Sci       Date:  2011-06-28       Impact factor: 5.923

8.  Tethering Cells via Enzymatic Oxidative Crosslinking Enables Mechanotransduction in Non-Cell-Adhesive Materials.

Authors:  Tom Kamperman; Sieger Henke; João F Crispim; Niels G A Willemen; Pieter J Dijkstra; Wooje Lee; Herman L Offerhaus; Martin Neubauer; Alexandra M Smink; Paul de Vos; Bart J de Haan; Marcel Karperien; Su Ryon Shin; Jeroen Leijten
Journal:  Adv Mater       Date:  2021-09-03       Impact factor: 32.086

9.  Spatiotemporal material functionalization via competitive supramolecular complexation of avidin and biotin analogs.

Authors:  Tom Kamperman; Michelle Koerselman; Cindy Kelder; Jan Hendriks; João F Crispim; Xandra de Peuter; Pieter J Dijkstra; Marcel Karperien; Jeroen Leijten
Journal:  Nat Commun       Date:  2019-09-25       Impact factor: 14.919

10.  Biocompatibility issues with modern implants in bone - a review for clinical orthopedics.

Authors:  Katja M R Nuss; Brigitte von Rechenberg
Journal:  Open Orthop J       Date:  2008-04-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.